Study to Compare Laser Assisted New Attachment Procedure (LANAP) to Traditional Treatments of Chronic Periodontitis

NCT ID: NCT01282229

Last Updated: 2015-10-14

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

59 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-10-31

Study Completion Date

2014-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the Laser Assisted New Attachment Procedure (LANAP protocol) using the Free-running (FR) Pulsed Neodimium: Yttrium aluminium garnet (Nd:YAG) laser to Scaling and Root Planing (SRP) alone, Modified Widman Flap (MFF) surgery, and Coronal Debridement (CD) alone with respect to periodontal clinical attachment level gain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This multi-center study of the Laser Assisted New Attachment Procedure (LANAP protocol) using the FR Pulsed Nd:YAG laser compared to Scaling and Root Planing alone, Modified Widman Flap (MWF) surgery, and Coronal Debridement (CD) alone will utilize a single-blind, four-quadrant split-mouth design with MWF as the positive control, CD as a weak positive control and SRP as the standard treatment control. The study will be conducted at three (3) to five (5) investigational centers. Subjects will receive the Laser Assisted New Attachment Procedure (LANAP protocol) using the pulsed FR Nd:YAG laser, Scaling and Root Planing alone, Modified Widman Flap surgery, and Coronal Debridement alone each in one quadrant of their mouth at Baseline. Treatment modalities are randomly assigned to quadrants at the time of treatment.

Efficacy evaluations, including clinical attachment level (CAL), probing depth (PD), and bleeding on probing (BOP) will be performed at Baseline, month 6, and month 12 using a Florida Electronic Probe. Radiographs will be taken at Screening/Baseline and at month 6 and month 12.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Periodontitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LANAP Quadrant

Treated with LANAP

Group Type ACTIVE_COMPARATOR

LANAP

Intervention Type DEVICE

Laser Assisted New Attachment Procedure (LANAP protocol) using the FR Pulsed Nd:YAG laser

Modified Widman Flap

Quadrant treated with Modified Widman Flap surgery

Group Type NO_INTERVENTION

No interventions assigned to this group

Scaling and Root Planing

Quadrant treated with scaling and root planing alone

Group Type NO_INTERVENTION

No interventions assigned to this group

Coronal Debridement

Quadrant treated with coronal debridement

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LANAP

Laser Assisted New Attachment Procedure (LANAP protocol) using the FR Pulsed Nd:YAG laser

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Periolase MVP 7

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subjects will have chronic adult periodontitis as characterized by all four quadrants of the mouth.
2. Subjects will be 25-75 years of age.
3. Subjects will be able to follow verbal and/or written instructions, perform Oral Hygiene according to the protocol, and return to the center for specified study visits.
4. Subjects must have had no subgingival scaling instrumentation including scaling and root planing, regular periodontal maintenance procedures or any subgingival cleaning \< 12 (twelve) months prior to Baseline examination.
5. Subjects must have had no history of periodontal surgical procedures of any type prior to Baseline examination.
6. Subjects must be non-smokers of any type or former smokers (\>6 (six) months stopped), and not using or taking any nicotine product.
7. Subjects will have clinical and/or radiographic evidence of subgingival calculus in each quadrant.
8. Subjects have no more than one missing tooth per quadrant, excluding 3rd molars.
9. Subjects will be able to sign the informed consent form.

Exclusion Criteria

1. Subject receiving subgingival scaling instrumentation including scaling and root planing, regular periodontal maintenance procedures or any subgingival cleaning less than twelve (12) months prior to Baseline examination.
2. Subjects receiving periodontal surgery of any type prior to Baseline examination.
3. Subjects with dental implants.
4. Subjects with a compromised heart condition, history of rheumatic fever, or joint replacement requiring prophylaxis.
5. Subjects having taken systemic cancer therapy and/or radiation therapy at any time
6. Subjects with clinically significant acute or concurrent illness
7. Subjects with clinically significant chronic illness.
8. Subjects with a disease of the connective tissue.
9. Subjects taking medications which are likely to cause gingival hyperplasia, within ONE MONTH prior to Baseline examination
10. Subjects taking antimicrobials within ONE MONTH prior to Baseline examination
11. Subjects taking non-steroidal anti-inflammatory drugs at a therapeutic dose within the TWO WEEKS prior to Baseline examination.
12. Subjects taking steroids of any kind within ONE MONTH prior to baseline examination.
13. Subjects taking continuous low doses of tetracycline within THREE MONTHS prior to Baseline examination
14. Subjects taking an investigational drug within TWO MONTHS prior to Baseline examination
15. Subjects taking or having taken bisphosphonates of any kind for any reason.
16. Female, nonsterile subjects who are pregnant or lactating.
17. Subjects who, in the investigator's opinion, would not comply with the study procedures.
18. Smokers of any type or former smokers and subjects that take or use any nicotine product.
19. Excessive alcohol intake.
20. No current restorative or endodontic treatment needs
Minimum Eligible Age

25 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institute for Advanced Laser Dentistry

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Raymund A Yukna, DMD, MS

Role: STUDY_DIRECTOR

University of Colorado Scholl of Dentistry

Henry Greenwell, DMD. MSD

Role: PRINCIPAL_INVESTIGATOR

University of Louisville, School of Dentistry

Mark Reynolds, DDS, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Maryland, School of Dentistry

James Finley, DMD

Role: PRINCIPAL_INVESTIGATOR

Finley Periodontics

Thomas McCawley, DDS

Role: PRINCIPAL_INVESTIGATOR

McCawly & DeTure

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Colorado

Denver, Colorado, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MDT MC 06-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy of Laser Therapy for Periodontitis
NCT07013162 NOT_YET_RECRUITING NA